ICD-10 Coding for Hepatocellular Carcinoma(B18.2U, C22.0, C22.0B)
Comprehensive guide on ICD-10 coding for hepatocellular carcinoma, including documentation requirements, code relationships, and common pitfalls.
Complete code families applicable to Hepatocellular Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C22.0 | Liver cell carcinoma | Use when imaging or biopsy confirms hepatocellular carcinoma. |
|
| C22.9 | Malignant neoplasm of liver, unspecified | Use when liver malignancy is suspected but not yet confirmed as HCC. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHepatocellular Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hepatocellular Carcinoma.
Using C22.9 when HCC is confirmed.
Impact
Clinical: Misrepresentation of patient condition., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Confirm diagnosis with imaging or biopsy before coding., Review documentation for specificity.
Incorrect sequencing of codes when HCC is secondary to another condition.
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Follow CMS etiology/manifestation rules to sequence underlying conditions first.
Code Sequencing
Impact
Incorrect sequencing of HCC and underlying conditions.
Mitigation
Educate coding staff on proper sequencing rules.